Join to view full profile
1250 8th AveSte 135Fort Worth, TX 76104
Phone+1 214-358-2300
Fax+1 214-579-6993
Dr. Fischbach is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Nephrology, 2000 - 2003
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1996 - 2000- Creighton University School of MedicineClass of 1996
Certifications & Licensure
TX State Medical License 2003 - 2026
KY State Medical License 2002 - 2004
TN State Medical License 2000 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2016-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Assessment of Renal Function in Cirrhotic Patients
- A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients
- A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant Start of enrollment: 2016 May 20
Publications & Presentations
PubMed
- Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.Jeffrey A Klein, David Taber, David Wojciechowski, Didier A Mandelbrot, Renata Glehn-Ponsirenas
Journal of the American Society of Nephrology. 2026-06-16 - 1 citationsProspective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates.Stevan A Gonzalez, Nagasri Shankar, Ashwini Mehta, Mauricio Garcia-Saenz-de-Sicilia, Goran B Klintmalm
Liver Transplantation. 2025-05-01 - Weight-based vs fixed dosing of darbepoetin alfa for anemia following kidney transplantation.Jonathan Solis, Nicole Wilson, Teena Sam, Tsung-Wei Ma, Angelito Yango
American Journal of Health-System Pharmacy. 2023-10-25
Journal Articles
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
Press Mentions
Kidney Disease Affects 26 Million Americans and Can Be PreventedMay 27th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: